AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Jazz Pharmaceuticals plc Director's Dealing 2024

Nov 5, 2024

Director's Dealing

Opens in your device viewer

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2024-11-01

Reporting Person: COZADD BRUCE C (Director, Chairman & CEO)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-11-01	Ordinary Shares	S	1000	$110.84	Disposed	428976	Direct

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2: Includes 167 ordinary shares acquired on May 31, 2024 under a Section 423 Employee Stock Purchase Plan.